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The syntheses of tetradentate ligand, meso-1,2-diphenyl-ethylenediamine-N,N'-di-3-propanoic acid 
(H2-1,2-dpheddp) and corresponding platinum(IV) and palladium(II) complexes are reported here. The 
spectroscopically predicted structure of the obtained palladium(II) complex was confirmed by X-ray 
analysis. Singe crystals suitable for X-ray measurements were obtained by slow crystallization from a 
DMSO-water mixture. Cytotoxic effects of platinum(IV), palladium(II) complexes and cisplatin on the 
4T1 and B16F1 cell lines were determined using the MTT colorimetric technique. The complexes showed 
a dose dependence on cytotoxic effect toward both cell lines. Both complexes were less active than cis-
platin, the exception was concentrations above 62.5 μM of platinum(IV) complex in the B16F1 cell line. 
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ЦИТОТОКСИЧНОСТ НА КОМПЛЕКСИТЕ НА ПЛАТИНА(IV) И ПАЛАДИУМ(II)  
СО meso-1,2-ДИФЕНИЛ-ЕТИЛЕНДИАМИН-N,N'-ДИ-3-ПРОПАНОНСКА КИСЕЛИНА.  
КРИСТАЛНА СТРУКТУРА НА КОМПЛЕКСОТ НА [Pd(1,2-dpheddp)]  
 
Во овој труд е опишана синтезата на тетрадентатниот лиганд, meso-1,2-дифенил-
етилендиамин-N,N'-ди-3-пропанонска киселина (H2-1,2-dpheddp), со соодветните комплекси на 
платина(IV) и паладиум(II). Спектроскопски предвидената структура на добиениот комплекс на 
паладиум(II) е потврдена со рендгенска структурна анализа. Монокристалите соодветни за 
рендгенските испитувања се добиени со бавна кристализација од воден раствор на DMSO. 
Цитотоксичните ефекти на комплексите на платина(IV) и на паладиум(II) врз типови на клетки 
4T1 и B16F1 се определени со MTT колориметрија и споредени со соодветните ефекти на 
цисплатин. Двата комплекса покажаа дозирачки зависен цитотоксичен ефект врз двата типа 
клетки. Двата комплекса покажаа послаба активност од онаа на цисплатин, со исклучок на 
повисоките концентрации (над 62,5 μM) на комплексот на платина(IV) спрема клетките B16F1. 
 
Клучни зборови: meso-1,2-дифенил-етилендиамин-N,N'-ди-3-пропанонска киселина;  
    платина(IV)-комплекс; паладиум(II)-комплекс;  
    кристална структура; цитотоксичност 
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1. INTRODUCTION 
 
Since the seventies, when cisplatin with anti-
tumor activity was discovered by Rosenberg and co-
workers [1, 2], thousands of platinum complexes 
have been synthesized in order to obtain a new plati-
num(IV) compound with improved properties in 
comparison to the parent drug cisplatin [3–5]. Plati-
num(IV) compounds are more inert than platinum(II) 
species and this property may allow oral usage. Jolley 
et al. [6] reported the synthesis and cytotoxicity of 
several platinum(II) and platinum(IV) complexes 
containing ethylenediamine derivatives, including the 
complex with the ethylenediamine-N,N'-diacetate 
ligand. The latter complex can be considered a vari-
ant of JM-216, having the carboxylate groups bonded 
to the amine ligands. The authors found that com-
plexes of the type [PtCl2(edda)] were less active than 
JM-216
 
(JM-216 is pharmaceutical abbreviation     
for the trans,cis,cis-diacetato-dichlorido-ammino-cy-
clohexylammino-platinum(IV)-complex, trans, cis, 
cis-[Pt(CH3COO)2Cl2(NH3)(c-C6H11NH2)]) [6]. 
Natile and co-workers investigated how the 
substitution of edda with eddp (eddp = ethylenedi-
amine-N,N'-di-3-propanoate ion) influenced their 
biological activity and concluded that eddp-Pt(IV) 
had lower activity than corresponding edda-Pt(IV) 
complex [7]. They supposed this fact due to the 
different complex geometry, s-cis in the case of 
edda and trans in the case of eddp.  
We wanted to extend the investigation of plat-
inum complexes with ethylenediamine-N,N'-di-3-
propanoate derivatives. The initial idea of this work 
was to prepare a new linear edda-like ligand, meso-
1,2-diphenyl-ethylenediamine-N,N'-di-3-propanoic 
acid and corresponding platinum(IV) complexes in  
s-cis and/оr trans geometries. In all of our attempts 
we prepared only the s-cis geometrical isomer, with a 
low solubility in water and common organic solvents. 
The preparation and spectral characteriza-
tion of meso-1,2-diphenyl-ethylenediamine-N,N'-
di-3-propanoic acid and corresponding plati-
num(IV) and palladium(II) complexes were pub-
lished earlier [8] using the same method as Liu [9]. 
In the present study, palladium(II) complex with 
meso-1,2-diphenyl-ethylenediamine-N,N'-di-3-pro-
panoic acid was characterized by X-ray analysis.  
The aim of this paper is to synthesize palla-
dium(II) and platinum(IV) complexes and research 
their cytotoxic effects in vitro. 
 
2. EXPERIMENTAL 
 
2.1. Materials and measurements 
 
The reagents were obtained commercially and 
used without further purification. Elemental analyses 
were done on a Vario III CHNOS Elemental Analyz-
er, Elemental Analysensysteme GmbH. 
 
2.2. Syntheses 
 
2.2.1. Preparation of meso-1,2-diphenyl-
ethylenediamine, 1,2-dphen 
 
The meso-1,2-diphenyl-ethylenediamine was 
prepared according to the procedure described 
earlier [10]. Benzaldehyde (30.00 g) was refluxed 
with ammonium-acetate (60.00 g) for 3 h. The 
reaction mixture was cooled and the product was 
filtered and washed with ethanol. After recrystalli-
zation from 1-butanol N-benzoyl-N'-benzylidene-
meso-1,2-diphenyl-ethylenеdiamine was obtained. 
Hydrolysis of that compound with 70% sulfuric 
acid under reflux for 1 h produced meso-1,2-
diphenyl-ethylenediamine as the basic product of 
hydrolysis. 
 
2.2.2. Preparation of meso-1,2-diphenyl-
ethylenediamine-N,N'-di-3-propanoic acid  
dihydrochloride-monohydrate,  
H2-1,2-dpheddp·2HCl·H2O 
 
3-Chloro-propanoic acid (4.34 g, 0.04 mol) 
was dissolved in 5.0 ml of water on ice and care-
fully neutralized with cold water solution of 5.0 ml 
NaOH (1.60 g, 0.04 mol). Meso-1,2-diphenyl-
ethylenediamine (4.24 g, 0.02 mol) was added to 
this solution. The mixture was stirred for 4 h at 
90°C, and during this period 5.0 ml NaOH water 
solution (1.60 g, 0.04 mol) was introduced. After 
that, 5.6 ml of 6 mol/l HCl was added and the re-
sulting solution was evaporated to the volume of 
7.0 ml; 6.0 ml conc. HCl, 6.0 ml of ethanol and 6.0 
ml of ether were added to the mixture. The white 
precipitate of meso-1,2-diphenyl-ethylenediamine-
N,N'-di-3-propanoic acid dihydrochloride mono-
hydrate, H2-1,2-dpheddp·2HCl·H2O was separated 
by filtration and refined with solution water : etha-
nol = 1 : 2. Yield: 4.00 g, 44.69%. Anal. Calcd. for 
H2-1,2-dpheddp·2HCl·H2O = C20H28Cl2N2O5 (Mr = 
447.344): C, 53.69; H, 6.31; N, 6.28. Found: C, 
53.88; H, 6.70; N, 6.08. 
 
2.2.3. Preparation of s-cis-dichlorido-(meso-1,2-
diphenyl-ethylenediamine-N,N'-di-3-propanoate)-
platinum(IV), s-cis-[PtCl2(1,2-dpheddp)] 
 
Potassium-hexachloridoplatinate(IV) (0.2000 
g, 0.411 mmol) was dissolved in 10.0 ml water on 
a steam bath and meso-1,2-diphenyl-ethylene-
diamine-N,N'-di-3-propanoic acid dihydrohloride 
Cytotoxicity of platinum(IV) and palladium(II) complexes with meso-1,2-diphenyl-ethylenediamine-N,N'-di-3-propanoic acid 
Maced. J. Chem. Chem. Eng. 35 (1), 79–86 (2016) 
81 
monohydrate (0.1839 g, 0.411 mmol) was added. 
The reaction mixture was heated for 12 h; during 
this period, 10.0 ml of LiOH water solution 
(0.0394 g, 1.65 mmol) was added in small portions 
and the solution was filtered and evaporated to a 
small volume. The orange precipitate of s-cis-
[PtCl2(1,2-dpheddp)] was separated by filtration, 
washed with cold water and air-dried. Yield: 0.095 g, 
37.25%. Anal. Calcd. for s-cis-[PtCl2(1,2-dpheddp)] 
= C20H26Cl2N2O4Pt (Mr = 620.396): C, 38.72; H, 
3.57; N, 4.52. Found: C, 38.38; H, 3.81; N, 4.60. 
 
2.2.4. Preparation of (meso-1,2-diphenyl-
ethylenediamine-N,N'-di-3-propanoate) palladi-
um(II) complex threehydrate,  
[Pd(1,2-dpheddp)]·3H2O 
 
K2[PdCl4] (0.2000 g, 0.613 mmol) was dis-
solved in 10.0 ml of water on a steam bath and 
meso-1,2-diphenyl-ethylenediamine-N,N'-di-3-pro-
panoic acid dihydrochloride monohydrate, H2-1,2-
dpheddp·2HCl·H2O (0.2742 g, 0.613 mmol) was 
added. The mixture was stirred for 2 h and during 
this period water solution of LiOH (0.059 g, 2.452 
mmol in 10.0 ml of water) was introduced. The 
complex [Pd(1,2-dpheddp)], as a yellow precipi-
tate, was filtered, washed with cold water and air-
dried. Yield: 0.25 g, 79.11%. Anal. Calcd. for 
[Pd(1,2-dpheddp)] = C20H28N2O7Pd (Mr = 514.864) 
(%): C, 46.65; H, 5.48; N, 5.44. Found: C, 46.64; 
H, 5.87; N, 5.31. 
 
2.3. X-ray experiment 
 
The diffraction data from a selected single 
crystal of [Pd(1,2-dpheddp)]·3H2O were collected 
at room temperature with an Oxford Diffraction 
Xcalibur Gemini S diffractometer equipped with 
CuKα radiation (λ = 1.5418 Å). Data were pro-
cessed with CRYSALIS software and corrected for 
absorption by numerical absorption correction 
method based on Gaussian integration over a mul-
tifaceted crystal model [11]. Crystal structure was 
solved by direct methods, using SHELXS [12] and 
refined using the SHELXL program [12]. 
Hydrogen atoms belonging to water mole-
cules were located in different Fourier maps and 
refined as riding, with O—H = 0.85 Å and Uiso(H) 
= 1.2Ueq(O). Hydrogen atoms attached to carbon 
and nitrogen atoms in the complex molecule were 
placed at geometrically calculated positions with 
C–H distances ﬁxed to 0.98, 0.97 and 0.93 Å from 
methine, methylene and phenyl C atoms, respec-
tively, and N–H distances ﬁxed to 0.91 Å. The 
corresponding isotropic displacement parameters 
of the hydrogen atoms were equal to 1.2 Ueq of the 
parent C and N atoms. The PARST [13] program 
was used to perform geometrical calculation and 
the program ORTEP [14]
 
was employed for mo-
lecular graphics. The crystallographic data are 
listed in Table 1. 
 
 
T a b l e  1 
 
Crystallographic data  
for [Pd(1,2-dpheddp)]·3H2O 
 
Empirical formula  C20H28N2O7Pd 
Formula weight  514.84 
Color, crystal shape Yellow, prism 
Crystal size (mm3) 0.38 × 0.23 × 0.14  
Temperature (K) 293(2)  
Wavelength (Å) 1.5418 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions:  
a (Å) 20.8248(5) 
b (Å) 8.9226(2)  
c (Å) 11.2833(2) 
V (Å
3
) 2096.57(8) 
Z 4 
Dcalc (Mg/m
3) 1.631  
μ (mm−1) 7.534  
θ range for data collection (°) 4.25 to 72.43 
Reflections collected 4787  
Independent reflections, Rint 2991,  0.0261 
Completeness (%) to θ = 67°  100.0 
Refinement method Full-matrix least-
squares on F2 
Data / restraints / parameters 2991 / 1 / 295 
Goodness-of-fit on F2 1.057 
Final R1/wR2 indices  [I >2σ(I)] 0.0283/ 0.0684 
Absolute structure parameter [15]  –0.021(9) 
Largest diff. peak and hole (e Å
-3
) 0.490 –0.535 
 
 
2.4. In vitro cytotoxicity studies 
 
2.4.1. Preparation of drug solutions 
 
Platinum complexes were dissolved in dime-
thylsulfoxide at a concentration of 20 mM and 
filtered through a 0.22 mm millipore filter. These 
stock solutions were diluted in culture medium 
immediately before use MTT, 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide was 
dissolved (5 mg/ml) in phosphate-buffered saline 
with a pH of 7.2, and filtered through the 0.22 mm 
millipore filter before use. All reagents were pur-
chased from Sigma Chemicals. 
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2.4.2. Cell lines 
 
The mouse breast tumor cell line 4T1 and 
mouse malignant melanoma cell line B16F1 were 
purchased from the American Type Culture Col-
lection (ATCC). The cells were maintained in 
RPMI 1640 supplemented with 10% fetal bovine 
serum (FBS), 100 IU/ml penicillin G and 100 
mg/ml streptomycin. 
 
2.4.3. Assessment of cytotoxicity 
 
Cytotoxic effects of platinum(IV) and palla-
dium(II) complexes and cisplatin on 4T1 and 
B16F1 cell lines were determined using the MTT 
colorimetric technique [16].
 
The cells were diluted 
with medium to 5·104 cells/ml and aliquots 
(5·103cells/100 µl) were placed in individual wells 
in 96-multiplates. Approximately 24 h after cell 
adherence, the medium was exchanged with 100 
µM of platinum(IV) and palladium(II) complexes, 
or cisplatin which had been serially diluted 2-fold 
in medium to concentrations ranging from 500 µM 
to 3.9 µM. Cells were incubated at 37°C in a 5% 
CO2 incubator for 72 h. After incubation superna-
tant was removed, 15% MTT (3-(4,5)-dimethyl-
thiazol-2-yl)-2,5-diphenyl-tetrazolium-bromide) (5 
mg/ml in phosphate buffered saline) was added to 
each well and the plates were incubated for an 
additional 4 h. Upon incubation the cell-free su-
pernatants were suctioned off, and DMSO (150 μl) 
and glycine buffer (20 μl) were added to dissolve 
the crystals. The plates were shaken for 10 
minutes. The optical density of each well was de-
termined at 595 nm using microplate multimode 
detector Zenyth 3100. The percentage of cytotoxi-
city was calculated using the formula: % cytotoxi-
city = 100–((TS−BG0)−E/(TS−BG0)×100), where 
“BG0” stands for background of medium alone, 
“TS” for total viability/spontaneous death of un-
treated target cells, and “E” for experimental well.  
 
3. RESULTS AND DISCUSSION 
 
Potassium-hexachloridoplatinate(IV) and po-
tassium-tetrachloridopalladate(II) react with meso-
1,2-diphenyl-ethylenediamine-N,N'-di-3-propanoic 
acid dihydrochloride monohydrate, H2-1,2-
dpheddp·2HCl·H2O in aqueous solution in the pres-
ence of lithium hydroxide to give the s-cis-dichlo-
rido-(meso-1,2-diphenyl-ethylenediamine-N,N' -di-3-
propanoate)-platinum(IV), s-cis-[PtCl2(1,2-dpheddp)] 
and (meso-1,2-diphenyl-ethylenediamine-N,N'-di-
3-propanoate)palladium(II) complex, [Pd (1,2-
dpheddp)], respectively.  
In the case of platinum(IV) complex with 
two additional monodentate ligands the linear ed-
da-type tetradentate ligands can occupy four of the 
sites around a central metal ion.  
 
3.1. Crystal and molecular structure  
of [Pd(1,2-dpheddp)]·3H2O 
 
The crystal structure of [Pd(1,2-
dpheddp)]·3H2O was determined by single-crystal     
X-ray analysis. The complex molecule together 
with the atom-labelling scheme is presented in 
Figure 1. The selected geometric parameters are 
listed in Table 2. 
 
 
 
 
Fig. 1. Molecular structure and atom-numbering scheme  
of [Pd(1,2-dpheddp)]. Displacement ellipsoids are drawn  
at 30% probability level 
 
 
The asymmetric unit consists of neutral 
complex molecule and three molecules of co-
crystallized water. The 1,2-dpheddp ligand has two 
halves that are equivalent in composition and la-
belled in the following text as fragments A and B. 
The central palladium atom is placed in a deformed 
square-planar environment formed by two N and 
two O donor atoms of tetradentate eddp derivative. 
In this coordination, atoms Pd1, O1a, O1b, N1a 
and N1b deviate from the corresponding mean 
plane by –0.008(2), 0.053(2), –0.050(2), –0.049(2) 
and 0.054(2) Å, respectively. The coordination 
bonds belonging to A and B fragments (Table 2) 
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show a noticeable difference in lengths which is 
more prominent for two Pd–N bonds (0.04 Å). The 
rest of the equivalent bonds in A and B halves of 
the molecule agree within the standard deviation 
limits. The coordination angles deviate from the 
ideal value of 90º by 4º on average. 
 
 
T a b l e  2 
 
Selected bond lengths (Å) and angles (°)  
for [Pd(1,2-dpheddp)]. The values for two 
 equivalent halves of the molecule are given  
in two columns labelled A and B. 
   
Bond A B 
Pd1−O1 2.004(4) 2.023(3) 
Pd1−N1 2.041(4) 2.004(4) 
N1−C3 1.490(5) 1.471(5) 
N1−C4 1.482(5) 1.498(6) 
C1−C2 1.534(7) 1.530(9) 
C2−C3 1.515(7) 1.506(6) 
O2−C1 1.233(6) 1.241(6) 
C4−C5 1.521(6) 1.519(6) 
C4a−C4b 1.537(6) 
Angle   
O1−Pd1−N1 94.98(14) 93.47(15) 
C3−N1−Pd1 109.4(3) 115.5(3) 
C1−O1−Pd1 128.7(3) 128.6(4) 
N1−C3−C2 112.9(4) 110.6(4) 
C1−C2−C3 118.7(4) 115.9(4) 
O1a−Pd1−O1b 86.57(15) 
N1a−Pd1−N1b 85.12(15) 
O1a−Pd1−N1b 176.47(16) 
O1b−Pd1−N1a 177.25(14) 
N1a−C4a−C4b 108.2(4) 
N1b−C4b−C4a 102.9(3) 
 
 
According to the Cambridge Structural Data-
base (CSD, Version 5.33 of 2012) [17], the present 
crystal structure is the only example of a palladi-
um(II) complex with eddp derivative. In the case of 
the other metal atoms, there are two octahedral 
complexes of platinum(IV) [18, 19] and square-
pyramidal complex of copper(II) with unmodified 
eddp ligand [20].
 
As previously observed in the 
complexes comprising propionate-chelates [18–21] 
the six-membered chelate rings of [Pd(1,2-
dpheddp)]·3H2O are essentially planar in their car-
boxylate parts and puckered in their amino parts.  
Two six-membered chelate rings in the pre-
sent crystal structure exhibit some noteworthy 
structural differences. Regarding the mean plane 
defined by Pd1/O1/C1/C2 (r.m.s. of fitted atoms is 
0.009 Å in both molecular halves), the atoms N1 
and C3 significantly deviate i.e. to opposite sides 
of the mean plane for –0.250(8) and 0.528(9) Å in 
fragment A and to the same side of the mean plane 
for –0.153(7) and –0.801(8) Å in fragment B. The 
O1–C1–C2–C3 torsion angle has the values of 25.7 
(8) and 34.1(6)° in the fragments A and B respec-
tively. The significant difference is also observed 
between the Pd–N1–C3 angles [109.4(3) and 
115.5(5)º in A and B fragments, respectively], 
while the equivalent bonds in two chelate rings 
have similar lengths (Table 2).  
The five-membered ring of the complex can 
be described as twisted on the C4a–C4b bond. 
Each of the C4 atoms attaches a phenyl substituent 
which takes equatorial and axial position in A and 
B parts of the ethylenediamine ring, respectively. 
This is described by torsion angle Pd1–N1–C4–C5, 
with corresponding values of –173.0(3) and 
81.8(4)º. The presence of voluminous phenyl sub-
stituents with dissimilar orientation induce the 
noticeable difference between N1a–C4a–C4b and 
N1b–C4b–C4a angles [108.2(4) and 102.9(3)º]. In 
the complexes comprising unmodified eddp ligand 
[18–20], the distribution of the angles within the 
ethylenediamine fragment is more consistent (from 
106.3 to 108.2º, not including the chelate angle).  
The two phenyl rings in [Pd(1,2-
dpheddp)]·3H2O are mutually inclined, forming 
the dihedral angle of 56.8(2)º. Although C4–C5 
single bonds allow for free rotation, the axially 
positioned phenyl ring takes specific orientation 
with C6b-H6b group clearly directed towards Pd 
atom. The torsion angle Pd1–C4b–C5b–C6b has 
the value of –1.34(5)º, while H6b…Pd1 distance of 
2.63 Å is significantly shorter than the sum of cor-
responding Van der Waals radii (3.50 Å).  
In general, the molecules of co-crystallized 
water have the most important role in the exten-
sive, three-dimensional hydrogen bonding network 
of [Pd(1,2-dpheddp)]·3H2O (Table 3). Each com-
plex unit interacts with six-molecules of co-
crystallized water, where the water molecules 
serve either as donors toward the carboxylate O 
atoms or as acceptors engaging the N–H groups. 
The crystal structure is also stabilized by means of 
weak C–H…O and C–H…π. 
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 T a b l e  3 
 
Hydrogen bonds and C−H… π interactions (Å, °) 
 
D−H…A D−H D…A H…A D−H…A 
N1a−H1a...O1wi 0.91 3.003(5) 2.12 163 
N1b−H1b...O2wi 0.91 2.824(7) 1.94 163 
O1w −H2w...O2aii 0.85 2.760(6) 1.98 153 
O2w−H3w…O3wi 0.85 2.796(7) 1.95 171 
O2w−H4w…O2biii 0.85 3.010(6) 2.19 160 
O2w−H4w…O1biii 0.85 3.186(7) 2.49 139 
O3w−H6w…O2biv 0.85 2.918(9) 2.13 155 
O3w−H5w…O1aiii 0.85 3.113(7) 2.33 154 
C−H… π C−H H… Cg H…Perp C−H…Cg 
C2a−H2a1...Cg2v 0.97 3.33 3.10 116 
C3b−H3b1...Cg1iv  0.97 2.97 2.97 126 
C8a−H8a...Cg2vi 0.93 3.07 2.99 121 
 
  Cg1 and Cg2 are centroids of phenyl rings in A and B fragments, respectively. Symmetry codes:  
  (i) x, y, z;   (ii) –x+1,–y, z–1/2; (iii) –x+3/2, y–1/2, z–1/2; (iv) x, y–1, z; (v) –x+1, –y, z–1/2; (vi) x, y+1, z.  
 
 
3.2. In vitro cytotoxic activity 
 
In order to investigate the in vitro cytotoxic 
potential of platinum and palladium complexes, 
various concentrations of complexes were added to 
target cells and the cell viability was determined 
after 72 h by MTT assay. The complexes showed a 
dose-dependence on cytotoxic effect toward both 
cell lines (Fig. 2 and Fig. 3). Platinum(IV) complex 
showed a higher cytotoxic effect compared to palla-
dium complex on both cell lines. Both complexes 
were less active than cisplatin, except at concentra-
tions of the platinum complex above 62.5 μM on the 
B16F1 cell line. Taking into consideration standard 
deviations, IC50 values for the B16F1 cell line were 
approximately the same (Pt – 223.38±25.12, Pd –
157.51±14.09, cisplatin – 186.63±28.11).  
 
 
 
 
Fig. 2. Cytotoxicity of investigated complexes and cisplatin  
on 4T1 cells. Cytotoxicity was determined by MTT assay after 
72 hours exposure to selected complexes. Data are presented 
as the means from three independent experiments.  
 
 
Fig. 3. Cytotoxicity of investigated complexes and cisplatin  
on B16F1 cells. Cytotoxicity was determined by MTT assay 
after 72 hours exposure to selected complexes. Data are  
presented as the means from three independent experiments. 
 
 
The platinum complex showed a significant-
ly higher cytotoxic effect on 4T1 cells (IC50 –
144.69±55.3) in comparison to the palladium com-
plex (IC50 – 31.94±13.38) and cisplatin (IC50 –
17.34±2.25) (Fig. 4 and Fig. 5). 
 
 
 
Fig. 4. IC50 (µM) for the 72 h of action of investigated com-
pounds on 4T1 cells, determined by MTT assay 
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Fig. 5. IC50 (µM) for the 72 h of action of investigated com-
pounds on B16F1 cells, determined by MTT assay 
 
 
4. CONCLUSION 
 
In this paper, we reported the cytotoxicity of 
platinum(IV) and palladium(II) complexes with 
meso-1,2-diphenyl-ethylenediamine-N,N'-di-3-pro-
panoic acid and the crystal structure of the [Pd(1,2-
dpheddp)] complex. Palladium(II) complex was 
crystallized in the form of the trihydrate. The cyto-
toxic effects of platinum(IV), palladium(II) com-
plexes and cisplatin on 4T1 and B16F1 cell lines 
were determined using the MTT colorimetric tech-
nique. In general, investigated complexes were less 
active than cisplatin, except for the concentrations 
of platinum(IV) complex above 62.5 μM on the 
B16F1 cell line. 
 
Acknowledgments. This work was supported by 
Ministry of Education, Science and Technological De-
velopment of Republic of Serbia, Projects No 172016, 
172034, 172035, ON175069, ON175071, ON175103. 
 
Appendix A. Supplementary data CCDC 930631 
contains the supplementary crystallographic data for this 
paper. These data can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from 
the Cambridge Crystallographic Data Centre, 12 Union 
Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223 336 
033; or e-mail: deposit@ccdc.cam.ac.uk. 
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